Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 281 to 290 of 356 resources
-
HMP Leeds: Treating hepatitis C in prison
In this good practice case study, Dr Iain Brew, GP at Leeds Community Services NHS Trust, talks to HCV Action about HMP Leeds' innovative hepatitis C treatment service. Dr Brew highlights prison as a highly effective setting in which to identify and treat people with hepatitis C.Yorkshire and the Humber 2014 Case study Video -
World Health Organisation (WHO) Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection
These are the first guidelines dealing with hepatitis C treatment produced by the World Health Organization (WHO) and complement existing guidance on the prevention of transmission of bloodborne viruses, including HCV. They are intended for policy-makers, government officials, and others working in low- and middle income countries who are developing programmes for the screening, care and treatment of persons with HCV infection.Rest of World Apr 2014 Tools & Templates, Strategy & Planning PDF -
Liver Disease: Today's Complacency, Tomorrow's Catastrophe. The All-Party Parliamentary Hepatology Group (APPHG) Inquiry into Improving Outcomes in Liver Disease
Out of disappointment at the persistent failure to develop a comprehensive approach to tackling liver disease, The All-Party Parliamentary Hepatology Group (APPHG) decided to conduct a comprehensive inquiry into the growing epidemic of liver disease. It invited evidence from Royal Colleges, clinicians, patients, charities, relevant industry figures, the NHS, Public Health England and the Government, in order to establish what needs to be done to improve outcomes for liver disease patients and save lives.UK 25 Mar 2014 Reports & Research PDF -
Hepatitis C Setting Standards in a Journey towards the Eradication of Infection and Disease as a Serious Health Issue in the EU
Initiatives which translate evidence and strategy into Hepatitis C Action are few and far between in the EU.UK, Rest of World 2014 Reports & Research, Strategy & Planning PDF -
Public Health England (PHE) Commissioning template for estimated HCV prevalence and numbers eligible for treatment by Drug Action Team Area (Excel Spreadsheet, 194 KB)This template has been produced by Public Health England (PHE) to help Local Authorities (LA) and Health and Wellbeing Boards estimate the prevalence of hepatitis C virus (HCV) infection in their local population, and the likely disease burden and associated treatment costs.UK 28 Feb 2014 Tools & Templates MS Excel
-
Charles Gore: A Call to HCV Action
A video call to action from Charles Gore, Executive Director of the Medicines Patent Pool, and ex-CEO of The Hepatitis C Trust, President of the World Hepatitis Alliance and HCV Action steering committee member.
UK, Rest of World 19 Nov 2013 Case study, Other Video -
Steve Callaghan: HCV Action Commissioning Toolkit
Steve Callaghan, who co-led development of the HCV Action Commissioning Toolkit, introduces the resource for commissioners of hepatitis C. The toolkit explains why effective commissioning for hepatitis C is essential, and gives advice on commissioning for outcomes under the new NHS by effectively assessing need, gathering evidence, developing services and measuring results.
UK Case study Video -
Shooting Up: Infections among people who inject drugs in the UK 2012: An update November 2013
A Public Health England update on the 2012 report, looking at changing patterns of injecting drug use in England; injection of image and performance enhancing drugs; changing patterns of psychoactive drug injection; and providing an update on infections and behaviours, as well as making recommendations.England Nov 2013 Reports & Research PDF -
The Uncomfortable Truth. Hepatitis C in England: The State of the Nation
Around 160,000 people in England have chronic hepatitis C, a preventable and treatable blood-borne virus that can lead to potentially fatal cirrhosis or cancer of the liver if left untreated. However, barriers to diagnosis, effective referral and treatment mean that many of these people are undiagnosed, and an increasing number are developing potentially fatal end stage liver disease.England Oct 2013 Reports & Research PDF -
HMP Kirkham pathway for clients at risk of hep C and testing positive for hep C
A case study from HMP Kirkham describing the hepatitis C pathway for prisoners, ensuring access to Hep C screening, treatment and ongoing community and medical support.
North West Oct 2013 Case study MS Word